Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a Study of IMR-687 in Healthy Adult Volunteers

NCT02998450 is registered in ClinicalTrials.gov with Cardurion Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02998450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02998450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a Study of IMR-687 in Healthy Adult Volunteers
Lead sponsor
Cardurion Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 18, 2016
Completion date
July 8, 2017
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle beta 0 thalassemia, sickle cell disease, sickle-cell; hb-sc